Skip to content

Acupotomy for postoperative hypertrophic scar pain and pruritus after total knee arthroplasty: a randomized controlled trial

Acupotomy for postoperative hypertrophic scar pain and pruritus after total knee arthroplasty: a randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054535
Enrollment
Unknown
Registered
2021-12-19
Start date
2022-04-20
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic scar after total knee replacement

Interventions

Experimental group:Acupotomy combined with exercise rehabilitation

Sponsors

Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Men and women aged 40 to 80 years; 2. Meet the diagnostic criteria for knee osteoarthritis; 3. 1-2 months after total knee arthroplasty, the wound healed well after thread removal, and there was no abnormal blood exudation; 4. Sign the written informed consent.

Exclusion criteria

Exclusion criteria: 1. The preoperative diagnosis is not simple knee osteoarthritis, but a combination of severe deformity, ligament injury around the knee joint, abnormal muscle strength and other diseases; 2. Postoperative scar expansion beyond the original damage range to the surrounding normal skin; 3. Coagulation disorders; 4. Postoperative diagnosis of superficial tissue infection of the incision or deep tissue infection of the incision; 5. Those who have serious physical and mental illness and cannot cooperate with the treatment; 6. Participate in other clinical researchers in the past 3 months.

Design outcomes

Primary

MeasureTime frame
The Western Ontario and McMaster Universities Pain Subscale;

Secondary

MeasureTime frame
Numerical Rating Scale;Vancouver Scar Rating Scale;Knee range of motion;Dosage of loxolophen sodium tablets;

Countries

China

Contacts

Public ContactLi Shuming

Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University

lishuming@bjzhongyi.com+86 10 52176050

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026